ATS awarded US $24 million assignment for biotechnology
automation
TSX: ATA
CAMBRIDGE, ON, Nov. 29 /CNW/ - ATS Automation Tooling Systems Inc. today
announced it has been awarded repeat orders totaling approximately
US$24 million (CDN $28 million) to manufacture specialized process automation
for a leading biotechnology manufacturing company.
The customer is scheduled to take delivery of this advanced automation in
numerous stages beginning in March 2006 and concluding in September 2006. This
automation - which takes advantage of ATS standard technology - will be
manufactured in the Company's North American operations and deployed at the
customer's facilities in the United States and Asia. The customer name and
further details could not be provided because of customer confidentiality.
"Securing this order is very rewarding to ATS not only because of its
size, but because the customer is strategic to us," said Ron Jutras, ATS
President and Chief Executive Officer. "It operates in one of the high-growth
areas of healthcare, it's a leader in its field and is a repeat customer. We
intend to build our future on customers like this who value our industry-
leading knowledge of automation, our technology, and our ability to serve
their needs on a global basis."
About ATS
ATS Automation Tooling Systems Inc. (www.atsautomation.com) is the
industry's leading designer and producer of turn-key automated manufacturing
and test systems, which are used primarily by multinational corporations
operating in a variety of industries including: healthcare, automotive,
computer/electronics and consumer products. ATS is also an emerging leader in
the rapidly growing market for solar energy cells and modules. The Company
also makes precision components and subassemblies using process knowledge and
automation technology. ATS employs approximately 4,000 people at 26
manufacturing facilities in Canada, the United States, Europe and
Asia-Pacific. The Company's shares are traded on The Toronto Stock Exchange
under the symbol ATA.
Certain forward-looking statements are made in this news release,
including statements regarding possible future results and business. Investors
are cautioned that such forward-looking statements involve risks and
uncertainties. The Company's results could differ materially from those
currently anticipated due to a number of factors including, but not limited
to, the risks and uncertainties contained in the Company's fiscal 2005 MD&A
and annual report and other risks detailed from time to time in ATS's periodic
reports filed with Canadian regulatory authorities.
%SEDAR: 00002017E
For further information: Carl Galloway, VP Treasurer; Gerry Beard, VP, CFO, (519) 653-6500